Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients-authors' response

被引：0
|
作者：
Molina, I. [1 ]
Falco, V. [1 ]
Crespo, M. [1 ]
Riera, C. [2 ]
Ribera, E. [1 ]
Curran, A. [1 ]
Carrio, J. [2 ]
Diaz, M. [1 ]
del Saz, S. Villar [1 ]
Fisa, R. [2 ]
Lopez-Chejade, P. [2 ]
Ocana, I. [1 ]
Pahissa, A. [1 ]
机构：
[1] Univ Autonoma Barcelona, Hosp Univ Vall Hebron, Dept Infect Dis, E-08193 Barcelona, Spain
[2] Univ Barcelona, Fac Farm, Parasitol Lab, E-08028 Barcelona, Spain
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2008年 / 61卷 / 02期
关键词：
leishmania; AMB; chemoprophylaxis;
D O I：
10.1093/jac/dkm490
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：467 / 467
页数：1
相关论文
共 50 条
  • [1] Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
    Molina, I.
    Falco, V.
    Crespo, M.
    Riera, C.
    Ribera, E.
    Curran, A.
    Carrio, J.
    Diaz, M.
    del Saz, S. Villar
    Fisa, R.
    Lopez-Chejade, P.
    Ocana, I.
    Pahissa, A.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (04) : 837 - 842
  • [2] Comment on: Efficacy of liposomal amphotericin B for secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
    Collazos, Julio
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 61 (02) : 466 - 467
  • [3] EFFICACY OF LIPOSOMAL AMPHOTERICIN-B IN THE TREATMENT AND SECONDARY PROPHYLAXIS OF VISCERAL LEISHMANIASIS IN HIV-INFECTED PATIENTS - REPORT OF 2 CASES
    DUPLA, ML
    AGUADO, AG
    URIOL, PL
    GARCIA, VP
    ORTEGA, EV
    MARTINEZ, PM
    GARCIAPUIG, J
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (04) : 657 - 659
  • [4] Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases
    Montana, M
    Chochoi, N
    Monges, P
    Ravaux, I
    Faraut, F
    Gensollen, S
    Bongrand, MC
    Timon-David, R
    Gallais, H
    [J]. PATHOLOGIE BIOLOGIE, 2004, 52 (02): : 66 - 75
  • [5] Amphotericin B lipid complex versus no treatment in the secondary prophylaxis of visceral leishmaniasis in HIV-infected patients
    López-Vélez, R
    Videla, S
    Márquez, M
    Boix, V
    Jiménez-Mejías, ME
    Górgolas, M
    Arribas, JR
    Salas, A
    Laguna, F
    Sust, M
    Cañavate, C
    Alvar, J
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (03) : 540 - 543
  • [6] Secondary prophylaxis for visceral leishmaniasis in HIV-infected individuals
    PerezMolina, JA
    LopezVelez, R
    [J]. AMERICAN JOURNAL OF MEDICINE, 1997, 102 (01): : 132 - 132
  • [7] Miltefosine for visceral leishmaniasis relapse treatment and secondary prophylaxis in HIV-infected patients
    Marques, Nuno
    Sa, Rosa
    Coelho, Filomena
    Oliveira, Joaquim
    Da Cunha, J. Saraiva
    Melico-Silvestre, A.
    [J]. SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 40 (6-7) : 523 - 526
  • [8] Visceral leishmaniasis in HIV infected patients: Treatment with high dose liposomal amphotericin B (AmBisome)
    Russo, R
    Nigro, LC
    Minniti, S
    Montineri, A
    Gradoni, L
    Caldeira, L
    Davidson, RN
    [J]. JOURNAL OF INFECTION, 1996, 32 (02) : 133 - 137
  • [9] Early efficacy of liposomal amphotericin B in the treatment of visceral leishmaniasis
    Castagnola, E
    Davidson, RN
    Fiore, P
    Tasso, L
    Rossi, G
    Mangraviti, S
    DiMartino, L
    Scotti, S
    Cascio, A
    Pempinello, R
    Gradoni, L
    Giacchino, R
    [J]. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1996, 90 (03) : 317 - 318
  • [10] VISCERAL LEISHMANIASIS IN HIV-INFECTED PATIENTS
    FLEGG, PJ
    BRETTLE, RP
    [J]. AIDS, 1990, 4 (04) : 366 - 367
12345